.Pharmacolibrary.Drugs.ATC.A.A07AA08

Information

name:Kanamycin
ATC code:A07AA08
route:intramuscular
n-compartments1

Kanamycin is an aminoglycoside antibiotic primarily used to treat severe bacterial infections such as tuberculosis caused by Mycobacterium tuberculosis and other susceptible bacteria. It is usually reserved for infections resistant to other antibiotics due to its potential toxicities. Kanamycin is approved but is less commonly used today due to the availability of less toxic alternatives.

Pharmacokinetics

Pharmacokinetic parameters reported for healthy adult individuals receiving kanamycin intramuscularly.

References

  1. Chang, MJ, et al., & Park, JS (2017). Population pharmacokinetics of moxifloxacin, cycloserine, p-aminosalicylic acid and kanamycin for the treatment of multi-drug-resistant tuberculosis. International journal of antimicrobial agents 49(6) 677–687. DOI:10.1016/j.ijantimicag.2017.01.024 PUBMED:https://pubmed.ncbi.nlm.nih.gov/28408267

Revisions


Generated at 2025-07-21T18:21:10Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos